 |
|
 |
COMPANY OVERVIEW
ALDA Pharmaceuticals Corp. has developed a novel infection control technology, T36®. which was originally developed for use as a hard surface disinfectant.
T36® kills viruses, fungi and bacteria, including resistance strains, such as MRSA, in as little as 15 seconds.
The first product for human use, T36® Antiseptic Hand Sanitizer has been approved by Health Canada.
This product has distinct advantages over typical alcohol hand sanitizers in that it kills a wider range of infectious organisms, and lasts for hours on the skin to provide continued protection.